Close it Thank you Вас интересует адвокация в сфере ТБ? Вы хотите помочь нам расширить понимание проблем ТБ в Европейском регионе? Тогда присоединяйтесь к нашей сети! Членство бесплатное.
Подпишитесь на наш список рассылки:





[recaptcha* recaptcha-40]

Resources and Reports
ХОРОШИЕ НОВОСТИ из КАЗАХСТАНА: Уровень заболеваемости туберкулёзом снизился за последние 10 лет.

ХОРОШИЕ НОВОСТИ из КАЗАХСТАНА: Уровень заболеваемости туберкулёзом снизился за последние 10 лет.

По данным Министерства здравоохранения и социального развития Республики Казахстан, страна зарегистрировала значительный прогресс в снижении уровня заболеваемости туберкулёзом и смертности в результате туберкулёза. За последние 10 лет уровень заболеваемости туберкулёзом в Казахстане снизился в 2,2 раза, а смертность – в 5 раз. В 2015 году, заболеваемость снизилась на 11,9% и составила 58,5 на 100 тысяч населения (в 2014 году — 66,4), смертность снизилась на 22,4% и составила 3,8 на 100 тысяч населения (в 2014 году — 4,9) (Министерство здравоохранения). Эффективность лечения впервые выявленных больных с чувствительным туберкулёзом в 2015 году улучшилась и составила 87,6% против 86,4% в 2014 году (стандарт Больше…

A new study highlights potential for social media to support MDR-TB patients

A new study highlights potential for social media to support MDR-TB patients

A study — “I can also serve as an inspiration” – a role for social media in supporting patients undergoing treatment for multidrug-resistant tuberculosis (MDR-TB)» – was published this week in PLOS ONE by Médecins Sans Frontières (MSF). It highlights the potential for social media to support patients undergoing treatment for multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). The qualitative research examined the experiences of patients and health staff involved in the ‘TB & ME’ collaborative blogging project for patients undergoing treatment for MDR and XDR TB around the world. The current treatment for MDR-TB can take up to Больше…

TB in Romania: For Patients Waiting for XDR-TB Treatment in Romania, Someday Never Comes

TB in Romania: For Patients Waiting for XDR-TB Treatment in Romania, Someday Never Comes

In March 2014, Jonathan Stillo, a member of TB Europe Coalition’s Steering Committee, participated in the joint World Health Organization (WHO) and European Centre for Disease Control (ECDC) National Tuberculosis (TB) Program Review in Romania on a team of eleven international and fifteen national experts. This blog does not necessarily reflect the positions of WHO or ECDC and should be seen as one research and advocacy expert’s opinion that is informed by eight years of working in Romania. The published 2014 review of Romania’s TB program should be available in early autumn. Right now, 30,000 Romanians have various forms of Больше…

TB in Romania: mapping the needs

TB in Romania: mapping the needs

The Romanian Angel Appeal Foundation and the Association for MDR-TB Patients Support conducted in February — March a survey among Romanian TB and MDR-TB patients, their families and specialists working in the field, in order to pinpoint the patients’ social, psychological and medical needs. The survey report was published in June and it shows the main needs reported by patients or identified by the professionals who work with them.  Context In 2013, more than 15,000 cases of tuberculosis (TB) have been diagnosed in Romania. According to the statistics provided by the National Tuberculosis Control Programme (NTP), 30,000 people with TB, Больше…

Practical tips to ensure the Global Fund delivers the impact communities need - Russian and English

Practical tips to ensure the Global Fund delivers the impact communities need — Russian and English

The Global Fund is encouraging all civil society organisations enusre that they are fully involved in the country dialogue and development of the concept note to ensure that their views are listened to and costed in any application submitted to the Global Fund. You can read more about this below both in English and Russian. In order to ensure active civil society engagemnet in Global Fund processes, the organisation have also released a brouchure that offers practical tips and advice on how civil society and key communities can get involved na dmake sure they play an active role. You can Больше…

An Activist's Guide to Tuberculosis Drugs

An Activist’s Guide to Tuberculosis Drugs

Treatment Action Group (TAG), an independent HIV/AIDS and TB research and policy think tank, have released an incredibly useful guide to TB drugs. You can access the guide here in order to find out about TB drugs, what they are used for, their side effects, whether they are in use and what the prospects are for their use in the future. As TAG themselves say, TB treatment must be shorter, simpler, less toxic, and more tolerable and affordable. Activists can contribute to the development and uptake of improved TB treatment by calling attention to research, quality of medications, and access priorities. Больше…

Only 1 in 3 MDR TB patients in Europe successfully complete treatment

Only 1 in 3 MDR TB patients in Europe successfully complete treatment

To mark World TB Day on 24 March 2014, the European Centre for Disease Prevention and Control (ECDC) and the World Health Organisation Regional Office for Europe have released their  joint TB surveillance and monitoring report for Europe 2014. While the report does make clear that, overall, the EU/EEA countries have met the target of an average five-year decline it is clear that there is much more that must be done to ensure we turn the tide against a disease which continues to destroy lives and livelihoods across the region. Perhaps the most shocking revelation is that countries have not Больше…

TB rates in some of Europe's biggest cities continue to increase

TB rates in some of Europe’s biggest cities continue to increase

A recent study published in Eurosurveillance has found that TB in western Europe is concentrated in big cities. Moreover, the research also found that while the number of TB cases continues to reduce in some countries in Europe the rate of TB within some the region’s largest cities continues to increase.  This is a marked change where rates of TB are showing an overall reduction but, conversely, an increase in big cities. The study looked into cities with populations greater than 500,000 from across the EU and concluded that in many cases the rate of TB in big cities was Больше…

TB: Voices in the fight against the European epidemic

TB: Voices in the fight against the European epidemic

The TB Europe Coalition recently released an updated version of our report ‘Tuberculosis: Voices in the fight against the European epidemic‘. Here we tell the story of Iulian. Since we first published Iulian’s story in our report, Iulian developed XDR-TB and passed away in spring of 2012, leaving behind a wife and two children. Iulian spent his life working in agriculture and construction. Until he got sick with TB he had what he called a ‘beautiful life’. Here is his story: Iulian contracted TB in 2007 and soon developed MDR-TB. At first he took his medication regularly, but he was Больше…

Azerbaijan achieves some of the best cure rates for drug-resistant TB in prisons

Azerbaijan achieves some of the best cure rates for drug-resistant TB in prisons

A new film produced for the International Committee of the Red Cross shows how Azerbaijan has managed to achieve some of the best cure rates for multi-drug resistant TB (MDR-TB) in prisons in the former Soviet Union and one of the best worldwide. The European region hosts some of the worst rates of MDR-TB in the world, particularly in countries formerly part of the Soviet Union. This is largely as a result of a disintegration of effective healthcare after the deterioration of the USSR. This meant that TB either went untreated or was treated improperly meaning that drug-resistant strains were able to Больше…

Comprehensive report on drug-resistant tuberculosis launches in the UK

Comprehensive report on drug-resistant tuberculosis launches in the UK

This week, the All Party Parliamentary Group on Global Tuberculosis (UK) launched a report — Drug-Resistant Tuberculosis: Old Disease, New Threat — highlighting the increasing concern that exists about growing rates of drug-resistant TB (DR-TB). The comprehensive piece was compiled after considerable time spent on processing both written and oral evidence from a number of experts in the field.The report identifies the main challenges facing not only the UK but also the world and outlines a series of recommendations for swift action where the biggest impact can be made. Importantly, the report highlights that it is not only developing countries Больше…

New report highlights the urgent need for action on childhood tuberculosis

New report highlights the urgent need for action on childhood tuberculosis

A new report, Children and Tuberculosis: From Neglect to Action, outlining recommendations on how the international community and affected countries can combat childhood TB was released today by the ACTION global health advocacy partnership.  Despite the international community paying increasing attention to the issue of childhood tuberculosis and despite it being both preventable and treatable, TB remains a top ten killer of children worldwide. The WHO estimates 490,000 children get sick with TB each year, and up to 64,000 die as a result — although experts agree that actual figures are much higher. The report highlights the various issues facing children, predominantly the Больше…

UA-22399108-3